Search the Community

The ultimate goal of an adverse event following immunisation (AEFI) investigation is to find the cause of the event and to implement follow-up actions when required. Investigation should identify any immunization error-related reactions because these are preventable. If coincidental events are recognized, proving them will be important to maintain public confidence in the immunization programme. Acknowledging that the cause of a large proportion of AEFI cannot be established by AEFI causality assessment committees due to incomplete AEFI investigation, WHO is launching an E-learning course on AEFI investigation to learn: 1) when to launch an investigation 2) what information is required to successfully complete an investigation 3) how to successfully manage inter-personal communication with relevant stakeholders. Learn at your own pace with a highly interactive course, with combination of informative content and immersive scenarios where you will be called upon to investigate serious AEFI in different parts of the world. Following successful course completion, you would download a course certificate.

FREQUENCE OBSERVEE DES REACTIONS POST-VACCINALES VACCINS A USAGE HUMAIN CONTRE LE CHARBON

INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS HAEMOPHILUS INFLUENZAE TYPE B (HIB) VACCINE

CDC, US: Healthcare providers play an important role in vaccine safety. It is up to healthcare providers to ensure that vaccines are stored, handled, and administered properly to ensure the best possible results. When talking with patients, healthcare providers ensure that patients receive the recommended vaccines. Providers share important information about vaccine benefits and risks, and answer questions about common vaccine safety concerns. Providers must be knowledgeable about precautions and contraindications and be prepared to manage vaccine reactions. Healthcare providers also contribute to what we know about vaccine safety by reporting adverse events. The Vaccine Adverse Event Reporting System (VAERS) relies on receiving adverse event information from providers. Talking to Patients About Vaccine Safety How to answer common questions about vaccine side effects and other vaccine safety issues. Reporting Adverse Events What adverse events to report, how to submit reports, and why. Resources for Healthcare Providers Vaccine safety training and continuing education, reports, and publications.

INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS VARICELLA ZOSTER VIRUS VACCINE

INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS TYPHOID VACCINE

INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS ROTAVIRUS VACCINE

INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS RABIES VACCINE

INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS POLIO VACCINES

INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS PNEUMOCOCCAL VACCINE

INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS MEASLES, MUMPS AND RUBELLA VACCINES

INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS JAPANESE ENCEPHALITIS VACCINE

INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS INFLUENZA VACCINE

INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS HUMAN PAPILLOMA VIRUS VACCINE

INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS HEPATITIS B VACCINE

INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS HEPATITIS A VACCINE

INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS DIPHTHERIA, PERTUSSIS, TETANUS VACCINES

INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS BACILLE CALMETTE-GUÉRIN (BCG) VACCINE

HOJA DE INFORMACIÓN SOBRE LAS TASAS OBSERVADAS DE REACCIONES A VACUNAS VACUNA CONTRA EL HAEMOPHILUS INFLUENZAE TIPO B (HIB)

HOJA DE INFORMACIÓN SOBRE LAS TASAS OBSERVADAS DE REACCIONES A VACUNAS VACUNA BACILO DE CALMETTE-GUÉRIN (BCG)

Health professionals are the single most important influence on whether individuals decide to have themselves or their children vaccinated. Therefore, information and education for health professionals are essential. The aim of this training manual is to present “state-of-the-art”, authoritative, scientifically valid advice to counter common misperceptions about vaccination.

This is a UNICEF and WHO joint guide for Communication for Investigation of Serious AEFIs. Contents: Why focus on communication? OBJECTIVES Communicating during the investigation of Serious AEFIs PRIOR TO REPORTS OF SERIOUS AEFIS AFTER REPORTS AND BEFORE THE INVESTIGATION OF SERIOUS AEFIS DURING THE INVESTIGATION OF SERIOUS AEFIS AFTER THE INVESTIGATION OF SERIOUS AEFIS Finding 1. The event is definitively not related to immunization (coincidental with only temporal association) Finding 2. The event is related to the operational aspects of immunization Finding 3. The event is related to inherent qualities of the vaccine and has occurred within the expected frequency range. Finding 4. The event is related to defects in the vaccine quality. Finding 5. The cause of the event is unknown or the results are inconclusive COMMUNICATION EVALUATION Communicating with the media GUIDING PRINCIPLES IN DEALING WITH THE MEDIA KEY MESSAGES NEWS RELEASE NEWS CONFERENCE NEWS INTERVIEW Resources

This is a case study/scenario of a HPV vaccine-safety related event for group exercises and training purposes. Owner WHO Geneva

Vaccine , Volume 36, Issue 40, 25 September 2018, Pages 5949-5954 Abstract Background Adverse events following immunization (AEFI) arising from anxiety have rarely been reported as a cluster(s) in the setting of a mass vaccination program. Reports of clusters of anxiety-related AEFIs are understudied. Social media and the web may be a resource for public health investigators. Methods We searched Google and Facebook separately from Atlanta and Geneva to identify reports of cluster anxiety-related AEFIs. We reviewed a sample of reports summarizing year, country/setting, vaccine involved, patient symptoms, clinical management, and impact to vaccination programs. Results We found 39 reports referring to 18 unique cluster events. Some reports were only found based on the geographic location from where the search was performed. The most common vaccine implicated in reports was human papillomavirus (HPV) vaccine (48.7%). The majority of reports (97.4%) involved children and vaccination programs in school settings or as part of national vaccination campaigns. Five vaccination programs were reportedly halted because of these cluster events. In this study, we identified 18 cluster events that were not published in traditional scientific peer-reviewed literature. Conclusions Social media and online search engines are useful resources for identifying reports of cluster anxiety-related AEFIs and the geographic location of the researcher is an important factor to consider when conducting these studies. Solely relying upon traditional peer-reviewed journals may seriously underestimate the occurrence of such cluster events.